Avalanche (AVAX) at $8.22 on Nov 13 after the NYSE selected it for tokenized securities: trend, momentum, timeframes, supply and news (Nov 14, 2026)
Published by Alexey Kovalyov, Founder, AstraEye Labs. Researched and written by its AI scientists.
Researched · Published
Introduction
AVAX closed at 8.22 on 13 November, drifting lower despite a wave of bullish news coverage led by the NYSE's reported selection of Avalanche for a tokenized securities platform. The central tension is between strongly positive fundamental developments and a technical picture that leans bearish across momentum and timeframe readings, with price sitting 14.6% below its 50-day average and just 1.6% above its 200-day average.
Bullish catalysts have failed to arrest a price slide that has now compressed AVAX between its 200-day average and its falling shorter-term averages. Coverage is unanimously positive across nine articles and three themes, yet two consecutive sessions lost ground and momentum carries three bearish votes against one bullish. When positive news does not lift price, sellers are absorbing demand. Against this: the positive MACD histogram, the sole bullish momentum vote, hints that the pace of decline may be slowing.
The 200-day average near 8.09 and support at 8.03 form a narrow cluster barely 2% below the close, making it the nearest technical test. With nearest resistance at 9.10 sitting 10.7% above the close and this support cluster only 2.3% below, the asymmetry of distance frames the next likely interaction as downward rather than upward. Against this: sideways trend classification means no established downtrend is in place, so the range could hold.
Dilution overhang is modest, with 94.7% of supply already circulating, though no unlock schedule was available to size near-term release risk. Potential dilution of about $202 million amounts to 5.6% of market cap, and the volume cushion of 1.23 times means daily trading volume slightly exceeds that figure. Small dilution removes one bearish variable but does not provide a catalyst. Against this: the absence of a vesting schedule means actual near-term supply pressure could differ from what the circulating share implies.
Findings
- As of 14 November 2026, AVAX is more likely to test the support cluster near 8.03 than to recover toward its 20-day average at 8.51 over the next two weeks.Horizon: 14 days, to 28 November 2026
Why: Three of four momentum votes are bearish, and intraday momentum on 14 November also reads bearish, reinforcing downward pressure toward the nearest floor.
What would change it: Price reclaims the 20-day average with rising volume.
- As of 14 November 2026, the gap between the close and the 50-day average is unlikely to narrow materially without a confirmed catalyst date or a shift in timeframe alignment.Horizon: 21 days, to 5 December 2026
Why: Weekly and monthly readings are neutral, not bullish, so no higher-timeframe tailwind exists to pull price toward the 50-day average sitting 17.1% above.
What would change it: Weekly timeframe flips bullish or NYSE event date is confirmed.
- Bullish catalysts have failed to arrest a price slide that has now compressed AVAX between its 200-day average and its falling shorter-term averages.
- The 200-day average near 8.09 and support at 8.03 form a narrow cluster barely 2% below the close, making it the nearest technical test.
- Dilution overhang is modest, with 94.7% of supply already circulating, though no unlock schedule was available to size near-term release risk.
What would change this read
A confirmed specific date for the NYSE tokenized securities launch, a weekly timeframe turning bullish, or a decisive break below the 200-day average at 8.09 would each materially change this read.
FELIX · Supply and Dilution
Bottom line
With nearly 95% of supply circulating and no unlock schedule available, dilution risk appears contained on the data at hand, though the missing schedule is a gap.
ATLAS · Technical Readings
Bottom line
The price is compressed into a narrow band between the 200-day average below and the falling 20-day average above, with the 50-day average far overhead.
NOVA · Catalysts and Sentiment
Bottom line
The NYSE partnership is the most concrete positive catalyst and the dominant coverage theme. The event pipeline beyond it is fuzzy in timing and tilted bearish, which may explain why price has not responded to the headline.
Questions and answers
Questions this research set out to answer
Where does AVAX stand against its 20-, 50- and 200-day averages?
AVAX closed at 8.22 on 13 November, 3.4% below its 20-day average of 8.512, 14.6% below its 50-day average of 9.625, and 1.6% above its 200-day average of 8.094. The 50-day average sits 17.1% above the close, while the 200-day average is only 1.5% below it.
What do the four momentum votes show?
Three of four momentum votes are bearish: price below the 20-bar average, price below the 50-bar average, and RSI at 41.51 below the 45 threshold. The sole bullish vote comes from the MACD histogram, which is positive. The resulting label is bearish.
Do the daily, weekly and monthly timeframes agree on direction?
They do not agree. The daily reading is bearish, while weekly and monthly are both neutral. This produces a leaning-bearish alignment with a score of 33.3 out of 100. No timeframe reads bullish.
What does the supply analysis report about upcoming token unlocks?
The circulating share is 94.7% of total supply. Potential dilution from the uncirculated portion is about $202 million, or 5.6% of market cap. The volume cushion, daily trading volume divided by that potential dilution, is 1.23 times. No vesting or unlock schedule was available, so no unlock date or release rate was estimated.
What does it say it does not measure?
The analysis states it is not a vesting or unlock schedule. It uses CoinGecko's circulating-supply count, not the project's own vesting data. The supply CoinGecko does not count as circulating may be locked, in a treasury, or not yet issued, and no unlock risk rating was assigned because no schedule was available.
What did coverage of Avalanche report over the window?
The overall coverage read is bullish across nine articles from seven sources.
Which events ahead carry a specific day?
No event carries a specific calendar day. One event, the NYSE tokenized securities selection, is dated by month only (November 2026). The remaining seventeen are dated approximately, by quarter, or with the date not confirmed.
Data sources
How these figures are produced and checked, the known limitations of this research, and how to report an error in it.
How this was computed
The analyses behind this report, each linked to its own public page.
Follow and more research
Follow an asset in this report and AstraEye Labs emails you the link when its next public report is published. Free, with an account. Impersonal research, not investment advice.
Your own research
AstraEye runs AI research on the stocks and crypto assets you choose, and SAGE, its research guide, explains what it found. Your first research report is on us, and it can cover AVAX: it starts as soon as you finish signing up, and the ticker goes on your watchlist.
Get a free research report on AVAXEvery stock you name, before each of its announced reports, from $19 a month
Research on the trading day before each announced report date, and again on the next weekday morning once the session after the report has closed.
- Before: how far the stock moved after its past earnings reports, how long each move took to settle, and the Volatility Outlook. After: the move, set against the stock's own history.
- Free for one stock, by email and on the web. Space Analyst covers up to 25 stocks and adds the company's own guidance beside our estimate, what the news says, and each report to read in ChatGPT or Claude.
- The Volatility Outlook's weekly forecasts are recorded before the market opens, and the result is published on 17 May 2027, whatever it shows.
- Love it, or get your first payment back: 14 days, for any reason
- Stock research subscriptions that self-directed investors pay for elsewhere list at $199 to $299 a year (November 2026). Space Analyst is $190 a year, or $19 a month.
- Founding offer: the first 100 members to subscribe to Space Analyst monthly on the web with the code FOUNDING pay half price, $9.50 a month today, for as long as they stay subscribed. For new subscriptions; changing plans ends it.
Already use ChatGPT? AstraEye Labs is listed in its own app directory: install it there, then sign in to AstraEye when it asks.
Open AstraEye Labs in ChatGPTNew to reports like this one? The guide How to research U.S. stocks and crypto with AI: one real report, step by step walks through each part of one and how to check its numbers.
Researching a move of your own? The guide Why did a stock or coin move? How to research a big move with AI shows how to set it beside the market, the news and positioning from the same days.